ALEXANDRA WOODRUFF: Open Payments
NPI 1750015855 · NATICK, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 48 payments from 14 companies in 2025. Trend: 2023 $21 · 2024 $686 · 2025 $1,184
Food & beverage: $1,084Education: $100
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $197 |
| UCB, Inc. | 7 | $152 |
| Incyte Corporation | 6 | $145 |
| Novartis Pharmaceuticals Corporation | 4 | $102 |
| ABBVIE INC. | 5 | $101 |
| LEO Pharma Inc. | 5 | $100 |
| GENZYME CORPORATION | 2 | $90 |
| Botanix SB Inc | 2 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Galderma Laboratories, L.P. | 3 | $46 |
Products named: Bimzelx, OPZELURA, DUPIXENT, SKYRIZI, COSENTYX, ADBRY, SOFDRA, Winlevi.
Industry payments across MA — which companies pay providers there.
